Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Daniel1977
    Junior Member
    • Mar 2013
    • 6

    No Replicates Cuffdiff; How does the 'variability model good fit' apply? and other...

    Hi,

    I want to clarify (in my head of course) how the system works so that I can make the proper choices when I use it.

    I have RNAseq data for several conditions, cell line with or without a virus (and deletion mutants) and/or different treatments (no biological/technical replicates, and yes I understand what this means in terms of the results).

    So, what Cuffdiff will do is ‘‘pool the conditions together to derive a dispersion model’’, which assumes that most genes won´t be differentially expressed then describes overall gene variances based on ‘expression’ levels (roughly; e.g. my gene’s fpkm is 500, I don´t know its variance as I do not have replicates, but most genes around that expression have a variance of 620, hence I will assign a variance of 620 to my gene for testing).

    Q1-Right?

    Next,’’ Cuffdiff assumes that gene's and transcripts with similar expression levels have similar variances in those expression levels. However, that's not always the case - some genes have unusually high variability, for biologically meaningful reasonss. Thus, Cuffdiff checks that the variability model is good fit before performing any signficance testing. This works as follows: Cuffdiff first calculates the expression level of the gene or transcript in each condition begin compared. It does so by pooling the data for the replicates of a condition together. The model gives an expression and variance estimate for each condition, along with confidence intervals around the expression estimates. Then, Cuffdiff calculates the expression level of the gene in each replicate independently. If the expression level of one or more replicates lies outside the confidence interval generated by the model, Cuffdiff flags the transcript as poorly fit by the model, and no signficance testing is performed.’’

    Q2-How does this apply to my setting (no replicates)?

    Q3- What exactly are the ‘NOTEST’ , ‘HIGHDATA’ and ‘FAIL’ flags?

    Q4- How does the –min-outlier-p option apply to the settings (no replicates)?

    Q5- Should I run Cuffdiff with all my conditions at once so that the variance model benefits from all the possible data instead of doing pairwise Cuffdiff runs?

    Q6- In case I want to use the expression values with tools not included in Cuffdiff (PCAs, correlations etc.) is the FPKM value alone the one to use?

    Any comments etc. would be greatly appreciated.
    D
  • Daniel1977
    Junior Member
    • Mar 2013
    • 6

    #2
    Any comments at least for Q4 and Q5?
    cheers

    Comment

    • Krish_143
      Member
      • Jan 2012
      • 45

      #3
      Incase if i do not have replicates,
      1) I will run cufdiff for 2 samples (ctl,sample1)(ctl,sample2)... do it for all and then compare all together.
      or
      a) I will preffer cufflinks 1st step (all samples), so i will have fpkm value for all the genes to all the samples and then based on gene of interest using R i will analyze the data.

      choose what you like.
      Last edited by Krish_143; 03-21-2013, 09:46 AM.
      Krishna

      Comment

      • Daniel1977
        Junior Member
        • Mar 2013
        • 6

        #4
        Thanks Kris_143.

        Yes one can always use the (a) option.

        But if you want to use cuffdiff it seems like a better option to run cuffdiff with all the conditions so that the variance model is more informed, hence you will probably get more precise results.

        Also regarding Q4 I´ve tried 0.01, 0.05 and 0.99 and got:

        P =0.99
        Performed 0 isoform-level transcription difference tests
        Performed 0 tss-level transcription difference tests
        Performed 38023 gene-level transcription difference tests
        Performed 0 CDS-level transcription difference tests

        P=0.05
        Performed 45266 isoform-level transcription difference tests
        Performed 40546 tss-level transcription difference tests
        Performed 38023 gene-level transcription difference tests
        Performed 39875 CDS-level transcription difference tests

        P=0.01
        Performed 45266 isoform-level transcription difference tests
        Performed 40546 tss-level transcription difference tests
        Performed 38025 gene-level transcription difference tests
        Performed 39875 CDS-level transcription difference tests

        It seems that it isn´t really doing anything (also from other comments in the post), but it puzzles me that the 0.99 option is devoid of all tests but the genes' .

        Comment

        • pengchy
          Senior Member
          • Feb 2009
          • 116

          #5
          For the experiment without any replicates, the following threads give suggestions:
          How to detect alternative splicing when there is no replicate
          DESeq, experimental design
          DESeq without replicates

          the document of DESeq also gives a pipeline for experiments without any replicates.
          Last edited by pengchy; 05-11-2013, 07:09 PM.

          Comment

          • Daniel1977
            Junior Member
            • Mar 2013
            • 6

            #6
            thanks for that, I´ll look into it.

            Comment

            • IBseq
              Member
              • Jul 2012
              • 56

              #7
              Hi Daniel77,
              did you get any answer on q1 and q2?
              I am also running cuffdiff without replicates and would like to understand how it does this

              thanks
              ibseq

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                Yesterday, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Yesterday, 11:10 AM
              0 responses
              8 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-13-2026, 10:26 AM
              0 responses
              30 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-09-2026, 10:04 AM
              0 responses
              39 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-08-2026, 10:08 AM
              0 responses
              25 views
              0 reactions
              Last Post SEQadmin2  
              Working...